GlaxoSmithKline Adds to its Commitment to GAVI Alliance

GlaxoSmithKline has agreed to provide an extra 240 million doses of Synflorix, a vaccine that protects against diseases such as pneumonia and meningitis, to developing countries over the next 10 years.
WorldPharmaNews